Literature DB >> 34357552

Neuroprotective effects of coenzyme Q10 in Parkinson's model via a novel Q10/miR-149-5p/MMPs pathway.

Elham Ghasemloo1, Hossein Mostafavi2, Masoumeh Hosseini3, Meysam Forouzandeh4, Mehdi Eskandari1, Seyyed Saeid Mousavi5.   

Abstract

Parkinson's disease (PD) is a complex neurodegenerative disease in which the understanding of the underlying molecular mechanisms can be constructive in the diagnosis and treatment. Matrix metalloproteinase (MMPs) elevation and damage to the blood-brain barrier (BBB) are critical mechanisms involved in the PD separation. Studies have revealed that changes in miR-149-5p and CoQ10 are associated with BBB damage, and CoQ10 can affect the levels of some miRs. Hence, in the present study, we aimed to evaluate CoQ10 and miR-149-5p mimic on miR-149-5p, MMPs and TH expression, and behavioral functions of the PD models. PD was induced by injection of 6-OHDA into the rats' Medial Forbrain Bundle (MFB). The behavioral tests, including the Rotation test, Rotarod test, and Open field test, have been directed two weeks after PD induction. Next, the MiR-149-5p mimic (miR-mimic) and CoQ10 have been administered to rats. The same behavioral tests have been evaluated two weeks after administration to investigate the effect of miR-149-5p mimic and CoQ10. The rats were followed extra four weeks, and the behavioral tests have performed again. Finally, the expression of MMPs and miR-149-5p genes was measured using RT-qPCR, and tyrosine hydroxylase (TH) was assessed through immunohistochemistry analysis. According to the obtained results, the level of miR-149-5p has decreased, followed by PD induction in rats. RT-qPCR analysis has represented upregulation and downregulation of miR-149-5p and MMP-2,9, respectively, after miR-mimic and CoQ10 treatment. The treated rats have also represented improved motor function and increased TH +  cells in the striatum according to the behavioral tests and immunohistochemistry assay. Taking together miR-149 and CoQ10 has shown to have an impressive potential to prevent damage to dopaminergic neurons caused by 6-OHDA injection through reducing MMP-2,9, increased TH expression, and improved motor function.
© 2021. The Author(s), under exclusive licence to Springer Science+Business Media, LLC, part of Springer Nature.

Entities:  

Keywords:  Coenzym Q10; Matrix metalloproteinase; Parkinson's disease; Tyrosine hydroxylase; miR-149-5p mimic

Mesh:

Substances:

Year:  2021        PMID: 34357552     DOI: 10.1007/s11011-021-00795-4

Source DB:  PubMed          Journal:  Metab Brain Dis        ISSN: 0885-7490            Impact factor:   3.584


  25 in total

1.  Caffeine protects against MPTP-induced blood-brain barrier dysfunction in mouse striatum.

Authors:  Xuesong Chen; Xun Lan; Ian Roche; Rugao Liu; Jonathan D Geiger
Journal:  J Neurochem       Date:  2008-09-20       Impact factor: 5.372

2.  New analytical strategies applied to the determination of Coenzyme Q10 in biological matrix.

Authors:  Mario Contin; Sabrina Flor; Manuela Martinefski; Silvia Lucangioli; Valeria Tripodi
Journal:  Methods Mol Biol       Date:  2015

3.  Pathogenesis-targeted therapeutic strategies in Parkinson's disease.

Authors:  Joseph Jankovic
Journal:  Mov Disord       Date:  2018-11-28       Impact factor: 10.338

4.  Formulation, characterization and pharmacokinetic studies of coenzyme Q₁₀ PUFA's nanoemulsions.

Authors:  Nabila Belhaj; François Dupuis; Elmira Arab-Tehrany; Frédéric M Denis; Cédric Paris; Isabelle Lartaud; Michel Linder
Journal:  Eur J Pharm Sci       Date:  2012-06-23       Impact factor: 4.384

Review 5.  International Parkinson and movement disorder society evidence-based medicine review: Update on treatments for the motor symptoms of Parkinson's disease.

Authors:  Susan H Fox; Regina Katzenschlager; Shen-Yang Lim; Brandon Barton; Rob M A de Bie; Klaus Seppi; Miguel Coelho; Cristina Sampaio
Journal:  Mov Disord       Date:  2018-03-23       Impact factor: 10.338

Review 6.  Effects of coenzyme Q10 supplementation on inflammatory markers: A systematic review and meta-analysis of randomized controlled trials.

Authors:  Li Fan; Yu Feng; Guo-Chong Chen; Li-Qiang Qin; Chun-Ling Fu; Li-Hua Chen
Journal:  Pharmacol Res       Date:  2017-02-05       Impact factor: 7.658

7.  Trabecular meshwork mesenchymal stem cell transplantation improve motor symptoms of parkinsonian rat model.

Authors:  Hossein Mostafavi; Leila Ghassemifard; Ali Rostami; Mohsen Alipour; Samad Nadri
Journal:  Biologicals       Date:  2019-06-29       Impact factor: 1.856

8.  miR-149* Suppresses Liver Cancer Progression by Down-Regulating Tumor Necrosis Factor Receptor 1-Associated Death Domain Protein Expression.

Authors:  Qingqing Feng; Hongli Zhang; Xiaobo Nie; Yuanqiang Li; Wei-Dong Chen; Yan-Dong Wang
Journal:  Am J Pathol       Date:  2019-11-26       Impact factor: 4.307

9.  Significant changes in circulating microRNA by dietary supplementation of selenium and coenzyme Q10 in healthy elderly males. A subgroup analysis of a prospective randomized double-blind placebo-controlled trial among elderly Swedish citizens.

Authors:  Urban Alehagen; Peter Johansson; Jan Aaseth; Jan Alexander; Dick Wågsäter
Journal:  PLoS One       Date:  2017-04-27       Impact factor: 3.240

10.  microRNA expression in peripheral blood cells following acute ischemic stroke and their predicted gene targets.

Authors:  Glen C Jickling; Bradley P Ander; Xinhua Zhan; Dylan Noblett; Boryana Stamova; Dazhi Liu
Journal:  PLoS One       Date:  2014-06-09       Impact factor: 3.240

View more
  3 in total

Review 1.  Coenzyme Q10 and Parkinsonian Syndromes: A Systematic Review.

Authors:  Félix Javier Jiménez-Jiménez; Hortensia Alonso-Navarro; Elena García-Martín; José A G Agúndez
Journal:  J Pers Med       Date:  2022-06-15

Review 2.  Evidence for Oxidative Pathways in the Pathogenesis of PD: Are Antioxidants Candidate Drugs to Ameliorate Disease Progression?

Authors:  Alexander Leathem; Tamara Ortiz-Cerda; Joanne M Dennis; Paul K Witting
Journal:  Int J Mol Sci       Date:  2022-06-22       Impact factor: 6.208

3.  Alpha-Synuclein Clearance through Inhibiting Akt/mTOR Pathway by Microfluidic Encapsulated Induced Conjunctival MSCs in a Parkinsonian Model.

Authors:  Meysam Forouzandeh; Mohammad Reza Bigdeli; Hossein Mostafavi; Samad Nadri; Mehdi Eskandari
Journal:  Iran J Pathol       Date:  2022-08-16
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.